Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antiparasitic Therapy for Neurocysticercosis: Phase II/III Study on Safety and Efficacy of Combined Treatment With Praziquantel and Albendazole

NCT00441285 is registered in ClinicalTrials.gov with Universidad Peruana Cayetano Heredia as lead sponsor.

NCT NCT00441285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00441285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antiparasitic Therapy for Neurocysticercosis: Phase II/III Study on Safety and Efficacy of Combined Treatment With Praziquantel and Albendazole
Lead sponsor
Universidad Peruana Cayetano Heredia
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2010
Completion date
September 30, 2013
Enrollment
156 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, neurocysticercosis